Literature DB >> 31943010

Effects of flanking sequences and cellular context on subcellular behavior and pathology of mutant HTT.

Anjalika Chongtham1,2, Douglas J Bornemann1, Brett A Barbaro1, Tamas Lukacsovich1, Namita Agrawal1, Adeela Syed1, Shane Worthge1, Judith Purcell1, John Burke1, Theodore M Chin2, J Lawrence Marsh1.   

Abstract

Huntington's disease (HD) is caused by an expansion of a poly glutamine (polyQ) stretch in the huntingtin protein (HTT) that is necessary to cause pathology and formation of HTT aggregates. Here we ask whether expanded polyQ is sufficient to cause pathology and aggregate formation. By addressing the sufficiency question, one can identify cellular processes and structural parameters that influence HD pathology and HTT subcellular behavior (i.e. aggregation state and subcellular location). Using Drosophila, we compare the effects of expressing mutant full-length human HTT (fl-mHTT) to the effects of mutant human HTTexon1 and to two commonly used synthetic fragments, HTT171 and shortstop (HTT118). Expanded polyQ alone is not sufficient to cause inclusion formation since full-length HTT and HTTex1 with expanded polyQ are both toxic although full-length HTT remains diffuse while HTTex1 forms inclusions. Further, inclusions are not sufficient to cause pathology since HTT171-120Q forms inclusions but is benign and co-expression of HTT171-120Q with non-aggregating pathogenic fl-mHTT recruits fl-mHTT to aggregates and rescues its pathogenicity. Additionally, the influence of sequences outside the expanded polyQ domain is revealed by finding that small modifications to the HTT118 or HTT171 fragments can dramatically alter their subcellular behavior and pathogenicity. Finally, mutant HTT subcellular behavior is strongly modified by different cell and tissue environments (e.g. fl-mHTT appears as diffuse nuclear in one tissue and diffuse cytoplasmic in another but toxic in both). These observations underscore the importance of cellular and structural context for the interpretation and comparison of experiments using different fragments and tissues to report the effects of expanded polyQ.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31943010      PMCID: PMC7608755          DOI: 10.1093/hmg/ddaa001

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  73 in total

1.  Specific covalent labeling of recombinant protein molecules inside live cells.

Authors:  B A Griffin; S R Adams; R Y Tsien
Journal:  Science       Date:  1998-07-10       Impact factor: 47.728

2.  Compartment-specific aggregases direct distinct nuclear and cytoplasmic aggregate deposition.

Authors:  Stephanie B M Miller; Chi-Ting Ho; Juliane Winkler; Maria Khokhrina; Annett Neuner; Mohamed Y H Mohamed; D Lys Guilbride; Karsten Richter; Michael Lisby; Elmar Schiebel; Axel Mogk; Bernd Bukau
Journal:  EMBO J       Date:  2015-02-11       Impact factor: 11.598

3.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

4.  Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death.

Authors:  J A Parker; J B Connolly; C Wellington; M Hayden; J Dausset; C Neri
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

5.  Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis.

Authors:  Y J Kim; Y Yi; E Sapp; Y Wang; B Cuiffo; K B Kegel; Z H Qin; N Aronin; M DiFiglia
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

6.  Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.

Authors:  G Schilling; M W Becher; A H Sharp; H A Jinnah; K Duan; J A Kotzuk; H H Slunt; T Ratovitski; J K Cooper; N A Jenkins; N G Copeland; D L Price; C A Ross; D R Borchelt
Journal:  Hum Mol Genet       Date:  1999-03       Impact factor: 6.150

7.  Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.

Authors:  Michelle Gray; Dyna I Shirasaki; Carlos Cepeda; Véronique M André; Brian Wilburn; Xiao-Hong Lu; Jifang Tao; Irene Yamazaki; Shi-Hua Li; Yi E Sun; Xiao-Jiang Li; Michael S Levine; X William Yang
Journal:  J Neurosci       Date:  2008-06-11       Impact factor: 6.167

8.  The influence of huntingtin protein size on nuclear localization and cellular toxicity.

Authors:  A S Hackam; R Singaraja; C L Wellington; M Metzler; K McCutcheon; T Zhang; M Kalchman; M R Hayden
Journal:  J Cell Biol       Date:  1998-06-01       Impact factor: 10.539

9.  Folding Landscape of Mutant Huntingtin Exon1: Diffusible Multimers, Oligomers and Fibrils, and No Detectable Monomer.

Authors:  Bankanidhi Sahoo; Irene Arduini; Kenneth W Drombosky; Ravindra Kodali; Laurie H Sanders; J Timothy Greenamyre; Ronald Wetzel
Journal:  PLoS One       Date:  2016-06-06       Impact factor: 3.240

10.  CCT complex restricts neuropathogenic protein aggregation via autophagy.

Authors:  Mariana Pavel; Sara Imarisio; Fiona M Menzies; Maria Jimenez-Sanchez; Farah H Siddiqi; Xiaoting Wu; Maurizio Renna; Cahir J O'Kane; Damian C Crowther; David C Rubinsztein
Journal:  Nat Commun       Date:  2016-12-08       Impact factor: 14.919

View more
  4 in total

1.  Nuclear and cytoplasmic huntingtin inclusions exhibit distinct biochemical composition, interactome and ultrastructural properties.

Authors:  Nathan Riguet; Anne-Laure Mahul-Mellier; Niran Maharjan; Johannes Burtscher; Marie Croisier; Graham Knott; Janna Hastings; Alice Patin; Veronika Reiterer; Hesso Farhan; Sergey Nasarov; Hilal A Lashuel
Journal:  Nat Commun       Date:  2021-11-12       Impact factor: 14.919

2.  A C-terminal ataxin-2 disordered region promotes Huntingtin protein aggregation and neurodegeneration in Drosophila models of Huntington's disease.

Authors:  Joern Huelsmeier; Emily Walker; Baskar Bakthavachalu; Mani Ramaswami
Journal:  G3 (Bethesda)       Date:  2021-12-08       Impact factor: 3.154

3.  Gut Bacteria Regulate the Pathogenesis of Huntington's Disease in Drosophila Model.

Authors:  Anjalika Chongtham; Jung Hyun Yoo; Theodore M Chin; Ngozi D Akingbesote; Ainul Huda; J Lawrence Marsh; Ali Khoshnan
Journal:  Front Neurosci       Date:  2022-06-02       Impact factor: 5.152

Review 4.  Emerging Therapies for Huntington's Disease - Focus on N-Terminal Huntingtin and Huntingtin Exon 1.

Authors:  M Leontien van der Bent; Melvin M Evers; Astrid Vallès
Journal:  Biologics       Date:  2022-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.